Here, we focused on STAT5 and GATA1, which carry potential binding sites in the TBX1 upstream region and, reportedly, play pathogenic roles in CML [37,38]. Here, TBX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.